Concepedia

Publication | Open Access

Community-driven development of a modified progression-free survival ratio for precision oncology

DOIFull Paper Access

40

Citations

12

References

2019

Year

Andreas Möck, Christoph E. Heilig, Simon Kreutzfeldt, Daniel Hüebschmann, Christoph Heining, Evelin Schröck, Benedikt Brors, Albrecht Stenzinger, Dirk Jäger, Richard F. Schlenk,
ESMO Open

Abstract

The modified PFS ratio may represent a meaningful clinical endpoint that could aid in the design and interpretation of future precision oncology trials.

References

YearCitations

Page 1